Every Form 4 that Northrop Grumman Corp. (NOC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NOC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NOC filings page.
Northrop Grumman director Arvind Krishna reported an award of 75 shares of common stock on September 30, 2026; the shares were deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan. The transaction lists $483.48 per share. Afterward, Krishna reported direct ownership of 2,837 shares of common stock, including dividends held in a stock unit account under the Plan.
Northrop Grumman director Marianne Catherine Brown acquired 96 shares of common stock on September 30, 2026, deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan. The transaction lists a reported per-share amount of $483.48. Her reported holdings after the transaction were 11,706 shares, including dividends held in the stock unit account.
NORTHROP GRUMMAN CORP (symbol: NOC) is the issuer of record for a Form 4 filing submitted to the SEC.
Northrop Grumman Corp. director Mark A III Welsh reported selling a total of 95 shares of common stock on August 3, 2026. The 10 open‑market transactions were executed at weighted‑average prices including $544.53 and $554.14 per share, pursuant to a pre‑arranged Rule 10b5‑1 trading plan adopted on August 23, 2025.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Marianne Catherine Brown received an award of 91 shares of common stock, valued at $509.31 per share, as a compensation grant. The shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, she holds 11,558 shares of common stock, including dividends, in the stock unit account pursuant to the plan, reflecting a routine, non–open-market equity compensation event.
KRISHNA ARVIND reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Arvind Krishna received 71 shares of common stock, valued at $509.31 per share, as a grant under the company’s 2024 Long-Term Incentive Stock Plan. The award was deferred into a stock unit account and is exempt under Rule 16b-3, bringing his directly held and deferred stock units to 2,749 shares.
Northrop Grumman director Mary A. Winston reported a compensation-related stock award rather than an open-market trade. She received 349 shares of common stock on May 20, 2026 as a grant or award at $552.17 per share, with the shares deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this acquisition, she directly holds 1,609 shares of common stock and indirectly holds 9 shares in an IRA. A footnote explains that her total amount also includes 78 shares of common stock and 1,540 shares of common stock equivalents, including dividends, held in stock unit accounts under current and prior long-term incentive plans.
WELSH MARK A III reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Mark A. Welsh III received a grant of 349 shares of common stock on May 20, 2026. The award was priced at $552.17 per share and was deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, he beneficially holds 4,470 shares and stock units in total, including 488 shares of common stock and 3,982 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s long-term incentive plans.
Turley James S reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director James S. Turley received an award of 349 shares of Common Stock valued at $552.17 per share. The shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Turley holds a total of 6,738 shares, including 635 shares of common stock and 6,103 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s current and 2011 long-term incentive stock plans.
SCHOEWE THOMAS M reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman Corp. director Thomas M. Schoewe received an award of 349 shares of common stock-equivalent units on May 20, 2026. The grant was priced at $552.17 per share and was made under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Schoewe’s holdings total 16,737 share equivalents, including 3,160 shares of common stock and 13,577 stock units (with dividends) held in plan-related stock unit accounts.
Northrop Grumman director Gary Roughead received an equity award of 349 common shares, valued at $552.17 per share, as a grant under the company’s long-term incentive plan. After this award, he directly holds 12,210 common shares. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan and are treated as an acquisition exempt from short-swing profit rules. Footnotes note that additional stock units, including dividend equivalents under current and prior long-term incentive plans, are maintained in this account but were not part of this new grant.
Ross Kimberly A. reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Kimberly A. Ross received an equity award of 349 shares of common stock, valued at $552.17 per share, as compensation. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Ross directly holds 1,612 shares, including dividends credited in stock unit accounts under the 2024 plan and the earlier 2011 Long-Term Incentive Stock Plan.
KRISHNA ARVIND reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Arvind Krishna received an award of 349 shares of common stock on May 20, 2026, at a reference price of $552.17 per share. The filing explains these shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Krishna directly holds 2,666 shares of common stock, including shares and dividends accumulated in stock unit accounts under the company’s long‑term incentive plans.
Northrop Grumman director Christopher W. Grady reported a compensation-related stock award. On May 20, 2026, he acquired 349 shares of Common Stock at a stated value of $552.17 per share through a grant under the Northrop Grumman 2024 Long-Term Incentive Stock Plan.
These shares were deferred into a stock unit account in a transaction exempt under Rule 16b-3. Following the award, Grady directly holds 421 shares of Northrop Grumman common stock, including amounts and dividends maintained in the stock unit account pursuant to the company’s long-term incentive plans.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Marianne Catherine Brown received a grant of 349 shares of common stock on May 20, 2026, as a compensation award. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, Brown directly holds a total of 11,415 shares of Northrop Grumman common stock, including shares and dividends held in stock unit accounts under the company’s long-term incentive plans.
Northrop Grumman director David P. Abney reported an award of common stock tied to the company’s long-term incentive plan. On May 20, 2026, he acquired 349 shares of Northrop Grumman common stock at $552.17 per share in a grant classified as a compensation-related acquisition rather than an open-market purchase.
According to the filing, these 349 shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, Abney’s directly held position is reported as 2,824 shares, consisting of 2,475 shares of common stock and 349 stock units, including dividends credited to the stock unit account.
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.
Northrop Grumman director Marianne Catherine Brown reported acquiring 68 shares of common stock valued at $682.24 per share on a deferred basis. The shares were credited to a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. Following this award, she holds 11,066 shares of common stock, including dividends, in the stock unit account pursuant to the plan. This reflects routine equity-based compensation rather than an open‑market stock purchase.
Northrop Grumman director Arvind Krishna reported an acquisition of 53 shares of common stock, valued at $682.24 per share, as a grant deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan. Following this compensation-related award, Krishna directly holds 2,317 shares of common stock.
Northrop Grumman Corporation corporate vice president and general counsel Kathryn G. Simpson reported an open-market sale of common stock. On March 2, 2026, she sold 873 shares of Northrop Grumman common stock at a price of $745.00 per share, in a transaction classified as a non-derivative sale. The filing notes that this sale was executed under a pre-established Rule 10b5-1 trading plan adopted on February 28, 2025. Following the sale, Simpson directly held 1.39 shares of Northrop Grumman common stock.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported an open-market sale of 1,754 shares of common stock at $720 per share on February 27, 2026. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on October 30, 2025. After the transaction, Roeder directly held 2,353.390 shares, plus an additional 116.7023 shares held indirectly in the Northrop Grumman Savings Plan as of February 27, 2026.
Northrop Grumman’s Corporate Vice President and General Counsel, Kathryn G. Simpson, reported an open-market sale of 194 shares of common stock on February 19, 2026. The shares were sold at an average price of $727.62 per share, and she held 874.39 shares directly afterward.
The filing notes that this sale was carried out under a pre-established Rule 10b5-1 trading plan, which Simpson adopted on February 28, 2025. Such plans are designed to systematically execute trades over time, helping insiders diversify holdings while reducing concerns about trading on nonpublic information.
Northrop Grumman Corporation executive Roshan S. Roeder, CVP & President of Mission Systems, sold 512 shares of common stock in an open-market transaction on February 19, 2026 at an average price of $727.62 per share. This sale, totaling roughly $372,000, was executed under a pre-established Rule 10b5-1 trading plan adopted on October 30, 2025. After the sale, Roeder directly held 4,107.39 shares of common stock and had an additional 115.9204 shares held indirectly in the Northrop Grumman Savings Plan, where balances are based on units that can change without an actual share acquisition or disposition.
Northrop Grumman Corp (NOC) insider Michael A. Hardesty, Corporate Vice President, Controller and Chief Accounting Officer, reported an open-market sale of common stock. He sold 147 shares of Northrop Grumman common stock at a price of $732.98 per share on February 19, 2026. Following this transaction, he directly owns 2,525.29 shares of the company’s common stock.
Northrop Grumman director Christopher W. Grady reported an equity award of common stock under the company’s long-term incentive program. On February 12, 2026, he acquired 71 shares of common stock at a reported price of $695.06 per share in a transaction categorized as a grant or award.
According to the disclosure, these shares were deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this award, Grady’s directly held stock unit account reflected 71 shares of common stock equivalents pursuant to the plan.
Northrop Grumman executive Benjamin R. Davies, Corporate Vice President and President of Defense Systems, reported several stock transactions. He sold 2,189.04 shares of common stock in an open‑market sale at a weighted average price of $719.61 per share, leaving 151 shares held directly.
On the prior day, 274 restricted stock rights were exercised into the same number of common shares, and 123 shares were withheld at $701.12 per share to cover tax obligations. Davies now holds 6,444 restricted stock rights that are scheduled to vest in stages between 2026 and 2029.
Northrop Grumman executive Robert J. Fleming reported equity award activity involving restricted stock rights and common shares. On 2/17/26, 264 Restricted Stock Rights were exercised, issuing 264 shares of common stock at a stated price of $0.0000 per share, reflecting the vesting of prior awards. In a related tax-withholding transaction, 85 common shares were disposed of at $701.12 per share to cover tax obligations, rather than through an open-market sale.
Following these transactions, Fleming directly held 2,619.03 shares of Northrop Grumman common stock. He also held 6,513 Restricted Stock Rights, which include grants under the company’s long-term incentive plans scheduled to vest on future dates.
Northrop Grumman corporate vice president, controller and chief accounting officer Michael A. Hardesty reported multiple share transactions on February 17, 2026. He acquired 538 Restricted Stock Rights that converted into 538 common shares at no cost upon vesting, then disposed of 243 shares to cover taxes and sold 715.94 shares in an open-market transaction at $700.63 per share, leaving him with 2,672.29 common shares directly owned. Footnotes note these shares vested from awards granted under the company’s long-term incentive stock plans and that additional Restricted Stock Rights remain scheduled to vest in later years.
Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity award activity tied to long-term incentives. On February 17, 2026, 2,152 Restricted Stock Rights (RSRs) vested and converted into an equivalent number of common shares at no exercise price under prior awards.
In connection with this vesting, 1,005 common shares were disposed of at $701.12 per share to cover tax obligations through share withholding, rather than an open-market sale. After these transactions, Jones directly held 11,204.715 common shares, plus 6,513 RSRs scheduled to vest between 2027 and 2029 under the company’s long-term incentive plans.
Northrop Grumman Chair, CEO and President Kathy J. Warden exercised 10,760 Restricted Stock Rights, receiving the same number of common shares at a stated price of $0.00 per share upon vesting on February 17, 2026. To cover tax obligations, 4,857 common shares were disposed of at $701.12 per share through a tax-withholding transaction, leaving her with 196,680.56 directly owned common shares after these transactions. The Restricted Stock Rights and shares were granted under the company’s long-term incentive stock plans and vest on specified future dates.
Northrop Grumman corporate VP and general counsel Kathryn G. Simpson reported several equity transactions in company stock. On February 17, 2026 she exercised 387 Restricted Stock Rights, receiving 387 common shares at a stated price of $0 per share. Of these, 193 shares were disposed of at $701.12 per share to cover tax obligations, and 779 shares were sold in an open-market transaction at $702.56 per share under a Rule 10b5-1 trading plan adopted on February 28, 2025. After these transactions, she directly held 1,068.39 common shares.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported a mix of equity award exercises and share disposals. On February 17, 2026, she exercised 2,017 Restricted Stock Rights, receiving an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations, 992 common shares were disposed of at $701.12 per share, and an additional 318 common shares were sold in the open market at $702.56 per share under a Rule 10b5-1 trading plan adopted on October 30, 2025. After these transactions, she directly held 4,619.39 common shares and 6,513 Restricted Stock Rights, alongside 115.9291 common shares held indirectly in the Northrop Grumman Savings Plan.
Northrop Grumman officer Michael A. Hardesty, Corp VP, Controller & CAO, reported two open-market sales of company common stock. On February 13, 2026, he sold 783 shares at $702.43 per share and 0.58 shares at $703.21 per share. Following these transactions, he directly owned 3,093.23 shares of Northrop Grumman common stock.
Northrop Grumman corporate vice president, controller and chief accounting officer Michael A. Hardesty reported equity award activity and related share withholding. On February 11, 2026, he acquired 1,382.16 Restricted Performance Stock Rights and 379 Restricted Stock Rights, both at an exercise price of $0 per right, as part of the company’s long-term incentive plans.
On the same date, 1,727.16 Restricted Performance Stock Rights were exercised into the same number of common shares at $0, increasing his direct common stock holdings. To cover tax obligations from the award settlement, 566 common shares were disposed of at $678.83 per share through tax withholding, leaving him with 3,876.81 common shares held directly.
Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity compensation activity. He received 5,927.1200 Restricted Performance Stock Rights and 1,701.0000 Restricted Stock Rights, and settled 6,910.1200 performance-based units into common stock, with 3,059.0000 shares withheld at $678.8300 per share for taxes. Following these transactions he holds 14,174 Restricted Performance Stock Rights and 10,057.715 shares of common stock directly.
Northrop Grumman’s corporate vice president and general counsel Kathryn G. Simpson received new stock-based compensation and settled prior awards. On February 11, 2026, she acquired 3,619.96 Restricted Performance Stock Rights (RPSRs) and 1,471 Restricted Stock Rights (RSRs), both granted at an exercise price of $0 under long‑term incentive plans.
She exercised 1,334.96 RPSRs, receiving the same number of common shares at $0, then had 461 shares withheld at $678.83 per share to cover tax obligations, leaving 1,653.39 common shares owned directly. Following these transactions, she directly holds 12,579.96 RPSRs and 5,555 RSRs, which may convert into common stock if performance and time‑based vesting conditions are met.
Warden Kathy J reported multiple insider transaction types in a Form 4 filing for NOC. The filing lists transactions totaling 121,361 shares at a weighted average price of $678.83 per share. Following the reported transactions, holdings were 102,064 shares.
Greene John reported acquisition or exercise transactions in a Form 4 filing for NOC. The filing lists transactions totaling 10,343 shares. Following the reported transactions, holdings were 4,981 shares.
Northrop Grumman executive Benjamin R. Davies reported multiple equity compensation transactions. On February 11, 2026, he was granted 4,710.32 Restricted Performance Stock Rights and 1,701 Restricted Stock Rights, each representing a contingent right to receive an equal number of common shares or, at the company’s election, cash or a mix of stock and cash.
On the same date, 3,158.32 Restricted Performance Stock Rights were exercised, delivering an equal number of common shares at an exercise price of $0. Of those shares, 1,214 common shares were disposed of at $678.83 per share to satisfy tax obligations, leaving 2,189.04 common shares held directly after the reported transactions, plus a small indirect position held in the Northrop Grumman Savings Plan.
Northrop Grumman executive Robert J. Fleming, CVP and President, Space Systems, received equity awards on 2026-02-11, including 3,982.16 Restricted Performance Stock Rights and 1,701 Restricted Stock Rights. He settled 913.16 performance rights into common stock, with 300 shares withheld at $678.83 per share for taxes. After these transactions he holds 14,174 Restricted Performance Stock Rights and 2,440.03 shares of common stock, all directly.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported multiple equity compensation transactions dated February 11, 2026. Roeder acquired 5,786.48 Restricted Performance Stock Rights (RPSRs) and 1,701 Restricted Stock Rights (RSRs), both at an exercise price of $0 per right, as part of long-term incentive plans.
On the same date, 6,476.48 RPSRs were exercised into the same number of common shares at $0, increasing direct common stock holdings to 6,880.39 shares before withholding. To cover tax obligations, 2,968 common shares were disposed of at $678.83 per share, leaving 3,912.39 common shares held directly after the transactions, plus 115.5111 shares held indirectly in the Northrop Grumman Savings Plan as of February 11, 2026.
Northrop Grumman (NOC) reported an insider sale by Chair, CEO and President Kathy J. Warden on February 6, 2026. She sold a total of 20,000 shares of common stock in multiple transactions at weighted average prices ranging from $705.84 to $711.14, with individual trade price ranges between $705.56 and $711.40. Following these sales, she directly owned 171,602.4 shares of Northrop Grumman common stock.
Northrop Grumman director Mark A. Welsh III reported open-market sales of 95 shares of common stock on February 2, 2026. The sales were made in multiple small trades under a Rule 10b5-1 trading plan adopted on August 23, 2025.
The reported transactions occurred at weighted average prices ranging from $676.14 to $689.31 per share. After these sales, Welsh directly beneficially owns 4,203 shares of Northrop Grumman common stock.
Northrop Grumman (NOC) Chair, CEO and President Kathy J. Warden reported two open-market stock sales under a pre-arranged Rule 10b5-1 trading plan. On January 5, 2026, she sold 7,000 shares of Northrop Grumman common stock at $600 per share. On January 6, 2026, she sold an additional 3,000 shares at $615 per share. These transactions were executed pursuant to a Rule 10b5-1 plan adopted on September 2, 2025. After the reported sales, she directly beneficially owns 191,602.4 shares of Northrop Grumman common stock.
Northrop Grumman Corporation director reports routine equity compensation activity. On 12/31/2025, the director acquired 64 shares of Northrop Grumman common stock at $570.21 per share through deferral into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this transaction, the director beneficially owned 2,257 shares in the stock unit account. The filing notes that dividends credited on shares in this account are exempt from Section 16 and were not required to be reported.
Northrop Grumman reported an equity transaction by a company director. On 12/31/2025, the director acquired 81 shares of Northrop Grumman common stock at $570.21 per share. These shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction that is exempt under Rule 16b-3.
Following this transaction, the director beneficially owned 10,963 shares of common stock in the stock unit account, which includes dividends credited under the plan. Dividends earned on these stock units were exempt from Section 16 reporting and therefore were not required to be reported as separate transactions.
Northrop Grumman Corporation executive CVP & President, Mission Systems reported a small open-market stock sale. On December 9, 2025, the reporting person sold 84 shares of common stock at a price of $555.35 per share, coded as a sale transaction. This trade was made under a pre-arranged Rule 10b5-1 trading plan adopted on February 11, 2025.
After this transaction, the reporting person beneficially owned 403.91 shares of Northrop Grumman common stock directly. In addition, 114.1531 shares were held indirectly through the Northrop Grumman Savings Plan, a qualified defined contribution plan, as of December 9, 2025, where unit accounting can change reported units without a new purchase or sale.
Northrop Grumman (NOC) executive reports stock transactions from restricted awards. On December 5, 2025, the company’s CVP & President, Mission Systems, exercised 328 Restricted Stock Rights, receiving the same number of common shares at an exercise price of $0. On the same date, 159 common shares were disposed of in a transaction coded “F,” reflecting shares withheld at a price of $548.97 per share, typically for tax purposes, leaving 646.91 common shares held directly afterward.
The reporting person also holds 114.1536 common shares indirectly through the Northrop Grumman Savings Plan as of December 5, 2025, where amounts are tracked using unit accounting. After the vesting and exercise activity, 6,829 Restricted Stock Rights remain beneficially owned as derivative securities, each representing a contingent right to receive one share of Northrop Grumman common stock or, at the issuer’s election, cash or a combination of cash and stock.
Northrop Grumman Corporation (NOC) reported insider activity by a director, who filed a Form 4 disclosing multiple open-market sales of common stock on 11/24/2025. The transactions were sales of very small share amounts, with prices ranging from about $560.39 to $566.15 per share. All sales are marked as dispositions and were made in the open market.
The director conducted these trades under a pre-established Rule 10b5-1 trading plan adopted on August 23, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following these transactions, the reporting person directly beneficially owns 4,281 shares of Northrop Grumman common stock.